BMV:XBI Holdings Information

BMV:XBI is an equity ETF with a total of 166 individual holdings. The top holdings are Twist Bioscience stock at 1.89%, Moderna at 1.83%, Natera at 1.61%, CRISPR Therapeutics AG at 1.53%, and Spyre Therapeutics at 1.52%.

Total Holdings

166

Top 10 Percentage

15.83%

Asset Class

Equity

ETF Category

Health Care

Assets

180.71B

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	TWST	Twist Bioscience Corporation	1.89%	1,222,381
2	MRNA	Moderna, Inc.	1.83%	1,131,452
3	NTRA	Natera, Inc.	1.61%	464,520
4	CRSP	CRISPR Therapeutics AG	1.53%	2,820,515
5	SYRE	Spyre Therapeutics, Inc.	1.52%	1,764,946
6	ABBV	AbbVie Inc.	1.51%	611,560
7	TGTX	TG Therapeutics, Inc.	1.50%	2,807,552
8	BIIB	Biogen Inc.	1.49%	728,105
9	HALO	Halozyme Therapeutics, Inc.	1.49%	1,428,699
10	GILD	Gilead Sciences, Inc.	1.48%	1,053,470
11	ORKA	Oruka Therapeutics, Inc.	1.46%	1,676,857
12	AMGN	Amgen Inc.	1.44%	392,175
13	BMRN	BioMarin Pharmaceutical Inc.	1.42%	2,382,082
14	PTGX	Protagonist Therapeutics, Inc.	1.42%	1,052,352
15	INCY	Incyte Corporation	1.42%	1,217,563
16	REGN	Regeneron Pharmaceuticals, Inc.	1.41%	189,964
17	EXEL	Exelixis, Inc.	1.40%	2,630,409
18	VRTX	Vertex Pharmaceuticals Incorporated	1.40%	294,466
19	ALKS	Alkermes plc	1.39%	3,379,564
20	UTHR	United Therapeutics Corporation	1.39%	302,774
21	PTCT	PTC Therapeutics, Inc.	1.38%	2,270,753
22	KRYS	Krystal Biotech, Inc.	1.37%	440,821
23	MDGL	Madrigal Pharmaceuticals, Inc.	1.37%	280,688
24	TVTX	Travere Therapeutics, Inc.	1.36%	2,317,009
25	ALNY	Alnylam Pharmaceuticals, Inc.	1.36%	594,664

Showing 25 of 166 holdings

Subscribe to see the full list

Activate Now

As of Sep 21, 2026